Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	SOX3 FOXS1 SOX5 LHX4 RBPJL GLIS3 ETV6 NR1H3 CHD2 ZBTB41 ZNF362 LHX8 RUNX1 FOXI3 CLOCK BHLHE40 PRDM2 HOXA5 HIVEP3 NFATC3 ZFHX2 FOXP1 ELK4 SNAPC4 SMAD2 ZNF574	2.19e-05	1459	147	26	GO:0000977
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SOX3 FOXS1 SOX5 RBPJL GLIS3 ETV6 NR1H3 CHD2 ZBTB41 ZNF362 RUNX1 FOXI3 CLOCK BHLHE40 HOXA5 HIVEP3 NFATC3 ZFHX2 FOXP1 ELK4 SNAPC4 SMAD2 ZNF574	3.97e-05	1244	147	23	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SOX3 FOXS1 SOX5 RBPJL GLIS3 ETV6 NR1H3 CHD2 ZBTB41 ZNF362 RUNX1 FOXI3 CLOCK BHLHE40 HOXA5 HIVEP3 NFATC3 ZFHX2 FOXP1 ELK4 SNAPC4 SMAD2 ZNF574	5.52e-05	1271	147	23	GO:0000987
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	SOX3 LHX4 RBPJL GLIS3 ETV6 NR1H3 RUNX1 CLOCK PRDM2 HOXA5 NFATC3 ELK4 SMAD2 ZNF574	6.92e-05	560	147	14	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	SOX3 LHX4 RBPJL GLIS3 ETV6 NR1H3 RUNX1 CLOCK PRDM2 HOXA5 NFATC3 ELK4 SMAD2 ZNF574	7.75e-05	566	147	14	GO:0001216
GeneOntologyMolecularFunction	GTPase activator activity	STARD13 TBC1D25 SRGAP2 GIT2 AGAP11 RGS14 TBC1D10B SIPA1L1 AGAP2	2.29e-04	279	147	9	GO:0005096
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	SOX3 FOXS1 SOX5 LHX4 RBPJL GLIS3 ETV6 NR1H3 ZBTB41 LHX8 RUNX1 FOXI3 CLOCK BHLHE40 PRDM2 HOXA5 HIVEP3 NFATC3 ZFHX2 FOXP1 ELK4 SMAD2 ZNF574	2.63e-04	1412	147	23	GO:0000981
GeneOntologyMolecularFunction	chromatin binding	CHAF1A RBPJL NR1H3 CHD2 CAMTA2 RUNX1 CLOCK AHDC1 ARID1B NFATC3 AUTS2 FOXP1 ASXL2 ELK4 SMAD2	3.70e-04	739	147	15	GO:0003682
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	STARD13 PSD TBC1D25 SRGAP2 GIT2 AGAP11 RGS14 TBC1D10B SIPA1L1 RGL2 AGAP2 SOS2	3.80e-04	507	147	12	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	STARD13 PSD TBC1D25 SRGAP2 GIT2 AGAP11 RGS14 TBC1D10B SIPA1L1 RGL2 AGAP2 SOS2	3.80e-04	507	147	12	GO:0030695
GeneOntologyMolecularFunction	phospholipid binding	AMPH PSD MAPT PCLO ATG2B GRB7 PARD3B AGAP11 GGA3 MICALL1 HAVCR1 PARD3	7.56e-04	548	147	12	GO:0005543
GeneOntologyBiologicalProcess	central nervous system development	SOX3 SOX5 SPHK2 LHX4 MAPT AVPR2 TACC2 SRGAP2 GIT2 LHX8 RUNX1 ATXN1L SHANK3 GHRH SHROOM4 MRTFB TENM4 SUDS3 CSNK1D NAV2 MAST1 FOXP1 TNFRSF1B	1.30e-05	1197	147	23	GO:0007417
GeneOntologyCellularComponent	chromatin	SOX3 FOXS1 SOX5 SPHK2 LHX4 INCENP CHAF1A RBPJL ETV6 NR1H3 CHD2 CAMTA2 LHX8 RUNX1 CLOCK BHLHE40 HOXA5 ARID1B KANSL1 NFATC3 SUDS3 MSL3 ZFHX2 FOXP1 ELK4 SMAD2	1.44e-05	1480	148	26	GO:0000785
GeneOntologyCellularComponent	distal axon	CACNA1B AMPH MAPT PTBP2 PCLO GIT2 GHRH AUTS2 KIF3C PARD3 AGRN	2.78e-04	435	148	11	GO:0150034
GeneOntologyCellularComponent	somatodendritic compartment	VGF CACNA1B PSD MAPT PTBP2 MARK3 PCLO SRGAP2 KCNB2 ATXN1L SHANK3 GHRH CNNM4 RGS14 SIPA1L1 MAST1 KIF3C TNFRSF1B PARD3 AGAP2	4.23e-04	1228	148	20	GO:0036477
MousePheno	abnormal rhythmic behavior	VGF CACNA1B KCNB2 CLOCK BHLHE40 PER3 CSNK1D KIF3C TNFRSF1B RAI1	1.17e-05	204	122	10	MP:0021121
MousePheno	abnormal spatial learning	VGF CACNA1B AMPH STIM2 MAPT LHX8 CLOCK SHANK3 RGS14 KANSL1 SIPA1L1	2.94e-05	276	122	11	MP:0001463
MousePheno	abnormal long-term object recognition memory	MAPT SHANK3 RGS14 KANSL1 AUTS2	3.86e-05	44	122	5	MP:0002801
MousePheno	decreased pituitary hormone level	VGF SOX3 LHX4 NR1H3 CLOCK GHRH RIMS2	5.83e-05	113	122	7	MP:0003972
MousePheno	abnormal circadian behavior	VGF CLOCK BHLHE40 PER3 CSNK1D RAI1	9.11e-05	84	122	6	MP:0020467
MousePheno	abnormal pituitary hormone level	VGF SOX3 LHX4 ACD NR1H3 CLOCK HOXA5 GHRH RIMS2	1.07e-04	214	122	9	MP:0003965
Domain	HnRNP-L/PTB	PTBP3 PTBP2 PTBP1	4.53e-06	5	145	3	IPR006536
Domain	PDZ	PCLO PARD3B SHANK3 SHROOM4 SIPA1L1 MAST1 PARD3 RIMS2	2.37e-05	151	145	8	PS50106
Domain	PDZ	PCLO PARD3B SHANK3 SHROOM4 SIPA1L1 MAST1 PARD3 RIMS2	2.49e-05	152	145	8	IPR001478
Domain	DUF3534	PARD3B PARD3	5.99e-05	2	145	2	IPR021922
Domain	DUF3534	PARD3B PARD3	5.99e-05	2	145	2	PF12053
Domain	PDZ	PARD3B SHANK3 SHROOM4 SIPA1L1 MAST1 PARD3 RIMS2	1.17e-04	141	145	7	PF00595
Domain	PDZ	PARD3B SHANK3 SHROOM4 SIPA1L1 MAST1 PARD3 RIMS2	1.58e-04	148	145	7	SM00228
Domain	-	PARD3B SHANK3 SHROOM4 SIPA1L1 MAST1 PARD3 RIMS2	1.72e-04	150	145	7	2.30.42.10
Domain	EST1	SMG7 SMG6	1.79e-04	3	145	2	PF10374
Domain	EST1_DNA_bind	SMG7 SMG6	1.79e-04	3	145	2	PF10373
Domain	EST1	SMG7 SMG6	1.79e-04	3	145	2	IPR019458
Domain	DNA/RNA-bd_Est1-type	SMG7 SMG6	1.79e-04	3	145	2	IPR018834
Pathway	KEGG_CIRCADIAN_RHYTHM_MAMMAL	CLOCK BHLHE40 PER3 CSNK1D	1.90e-06	13	104	4	M18009
Pubmed	A census of human transcription factors: function, expression and evolution.	SOX3 FOXS1 SOX5 LHX4 RBPJL ETV6 NR1H3 CAMTA2 LHX8 RUNX1 FOXI3 CLOCK BHLHE40 PRDM2 HOXA5 HIVEP3 ZC3H11A NFATC3 PRDM12 ZFHX2 FOXP1 ELK4 SNAPC4 SMAD2	1.73e-12	908	152	24	19274049
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	EP400P1 MAPT PTBP2 MARK3 UVSSA PARD3B CHD2 SRGAP2 ZNF362 KLKP1 RBBP8NL AHDC1 LRCH3 HIVEP3 CNNM4 KMT2C ZC3H11A MRTFB SMG7 CSNK1D KIAA1217 AUTS2 MAST1 ZFHX2 FOXP1 ELK4 PARD3 RAI1 SMG6 SOS2	2.14e-12	1489	152	30	28611215
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	STIM2 MAPT MARK3 PARD3B SRGAP2 MICALL1 PIK3R4 TBC1D10B NFATC3 CSNK1D MAP4K1 KIAA1217 SIPA1L1 NAV2 AKAP11 SSH2 PARD3 SRRM2 PLEKHA7 CAMSAP2 RGL2 PRRC1	3.06e-11	861	152	22	36931259
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP36 UVSSA LRRK1 AGAP11 CLOCK GGA3 MICALL1 KMT2C ARID1B SMG7 NAV2 AUTS2 BOP1 AKAP11 RIMS2 RAI1 SMG6	2.00e-10	529	152	17	14621295
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SPHK2 PCNX3 TBC1D25 SRGAP2 LRRK1 BCL9 STK11IP AHDC1 GGA3 MICALL1 HIVEP3 KMT2C ZC3H11A KANSL1 TMEM259 XPO6 NAV2 SLC45A1 SNAPC4 RGL2 AGRN RAI1 SMG6	5.82e-10	1105	152	23	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MARK3 CAMTA2 FHIP2A GGA3 KIAA0319 ZC3H11A TENM4 KANSL1 MEGF9 SIPA1L1 MAST1 ASXL2 SRRM2 CAMSAP2	3.64e-09	407	152	14	12693553
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	GIT2 KMT2C MRTFB TENM4 SMG7 XPO6 SIPA1L1 NAV2 AUTS2 AKAP11 SMG6	5.06e-09	225	152	11	12168954
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	MAPT CHAF1A NIBAN2 RUNX1 BCL9 PRDM2 MICALL1 TBC1D10B ZC3H11A KANSL1 XPO6 MAP4K1 SIPA1L1 MSL3 SNAPC4 PARD3 SRRM2 CNOT3	9.38e-09	774	152	18	15302935
Pubmed	Interaction network of human early embryonic transcription factors.	SOX5 BCL9 ATXN1L AHDC1 PRDM2 KMT2C ARID1B SUDS3 AUTS2 FOXP1 ASXL2 RAI1	5.32e-08	351	152	12	38297188
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	PTBP2 CHD2 ZBTB41 TACC2 SRGAP2 CAMTA2 ATXN1L PRDM2 HAVCR1 KMT2C ARID1B ZC3H11A SIPA1L1 BOP1 TMEM131 ASXL2 PARD3 PLEKHA7 AGRN SMAD2	6.20e-08	1084	152	20	11544199
Pubmed	Expression of human nPTB is limited by extreme suboptimal codon content.	PTBP3 PTBP2 PTBP1	8.18e-08	3	152	3	18335065
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	VGF PRR36 SRGAP2 GIT2 BCL9 SHANK3 KIAA0319 NFATC3 TMEM259 KIAA1217 SIPA1L1 SSH2 PARD3 CAMSAP2 AGRN RAI1 AGAP2 SMG6	2.47e-07	963	152	18	28671696
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	STIM2 RBM33 KCNB2 GGA3 POM121 SMG7 KIAA1217 TMEM131 PARD3 PLEKHA7	2.70e-07	263	152	10	34702444
Pubmed	Liver X receptors (LXRalpha and LXRbeta) are potent regulators for hepatic Dec1 expression.	NR1H3 CLOCK BHLHE40	3.26e-07	4	152	3	19032342
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	AMPH PCLO SRGAP2 AGAP11 KCNB2 SHANK3 SIPA1L1 AKAP11 RIMS2 AGAP2	4.94e-07	281	152	10	28706196
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	USP36 PCNX3 RBM33 MARK3 CHAF1A ETV6 CHD2 SRGAP2 AHDC1 LRCH3 KMT2C ZC3H11A MRTFB SIPA1L1 BOP1 PARD3 PLEKHA7 CAMSAP2 AGRN CNOT3 ZNF574 SMG6	6.43e-07	1497	152	22	31527615
Pubmed	Polypyrimidine tract-binding proteins are essential for B cell development.	PTBP3 PTBP2 PTBP1	8.13e-07	5	152	3	32081131
Pubmed	PTBP1 is required for embryonic development before gastrulation.	PTBP3 PTBP2 PTBP1	8.13e-07	5	152	3	21423341
Pubmed	CLOCK gene variants associate with sleep duration in two independent populations.	CLOCK PER3 CSNK1D	8.13e-07	5	152	3	20149345
Pubmed	Human transcription factor protein interaction networks.	SOX5 LHX4 RBM33 ETV6 LHX8 BCL9 ATXN1L PRDM2 HOXA5 KMT2C ARID1B KANSL1 SMG7 NFATC3 SUDS3 AUTS2 FOXP1 ASXL2 ELK4 SRRM2 CNOT3	1.19e-06	1429	152	21	35140242
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	RBM33 ETV6 ZNF362 AASDH PTBP1 RUNX1 BCL9 ATXN1L AHDC1 PRDM2 KMT2C ARID1B ZC3H11A FOXP1 ASXL2 SRRM2 MNDA RAI1	1.73e-06	1103	152	18	34189442
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	MARK3 PARD3B SRGAP2 GIT2 LRCH3 MICALL1 PIK3R4 PARD3 SRRM2	2.00e-06	255	152	9	15324660
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	STIM2 MARK3 PARD3B SRGAP2 NIBAN2 LRCH3 TBC1D10B KIAA1217 PARD3 PLEKHA7 SMAD2	2.70e-06	421	152	11	36976175
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	RBM33 ZNF362 BCL9 ATXN1L AHDC1 ARID1B SUDS3 FOXP1 RAI1	3.01e-06	268	152	9	33640491
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	GLIS3 ETV6 TUT1 RUNX1 CLOCK MSL3 AKAP11 CNOT3 SMG6	4.55e-06	282	152	9	23667531
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	MARK3 ETV6 TACC2 AGAP11 AHDC1 TENM4 KANSL1 KIAA1217 SIPA1L1 FOXP1 PARD3 SMG6	4.59e-06	536	152	12	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	MARK3 ETV6 TACC2 AGAP11 AHDC1 TENM4 KANSL1 KIAA1217 SIPA1L1 FOXP1 PARD3 SMG6	4.76e-06	538	152	12	10512203
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	MARK3 GRB7 PARD3B SIPA1L1 PARD3 SRRM2	6.02e-06	102	152	6	15778465
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	FOXS1 LHX4 CHAF1A RBPJL GLIS3 NR1H3 CLOCK BHLHE40 HOXA5 NFATC3 FOXP1 SNAPC4 CNOT3 SMAD2 RAI1	7.65e-06	877	152	15	20211142
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	MARK3 SRGAP2 NIBAN2 GGA3 MICALL1 TBC1D10B MRTFB CSNK1D KIAA1217 NAV2 PARD3 PLEKHA7	7.80e-06	565	152	12	25468996
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CACNA1B AMPH STIM2 MAPT PCLO ATG2B TACC2 PTBP1 KCNB2 SHANK3 PRUNE1 TENM4 KIAA1217 SIPA1L1 CAMSAP2 CNOT3 AGAP2	1.10e-05	1139	152	17	36417873
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SOX3 SOX5 GLIS3 ETV6 NR1H3 ZBTB41 LHX8 CLOCK BHLHE40 HIVEP3 PER3 FOXP1 SNAPC4 SMAD2	1.35e-05	808	152	14	20412781
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	USP36 ACD CHAF1A CHD2 PTBP1 RUNX1 CLOCK BHLHE40 AHDC1 PRDM2 KMT2C ZC3H11A KANSL1 SUDS3 MSL3 ASXL2 SRRM2 RAI1	1.53e-05	1294	152	18	30804502
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	GIT2 GGA3 SMG7 SIPA1L1 BOP1 AKAP11 PLEKHA7 CAMSAP2	1.58e-05	251	152	8	29778605
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	AMPH PRR36 MAPT MARK3 PCLO SRGAP2 PTBP1 SHANK3 LRCH3 PIK3R4 TENM4 CSNK1D KIAA1217 SIPA1L1 MAST1 SSH2 PLEKHA7 CAMSAP2 AGAP2	1.67e-05	1431	152	19	37142655
Pubmed	Systematic Identification of Oncogenic EGFR Interaction Partners.	AMPH RIMS2 SKAP2	1.75e-05	12	152	3	27956147
Pubmed	Mechanism of transcriptional repression by TEL/RUNX1 fusion protein.	ETV6 RUNX1	1.90e-05	2	152	2	15179033
Pubmed	ETV6-RUNX1 transcript is not frequent in early human haematopoiesis.	ETV6 RUNX1	1.90e-05	2	152	2	18462252
Pubmed	ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling.	ETV6 RUNX1	1.90e-05	2	152	2	21224468
Pubmed	CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia.	ETV6 RUNX1	1.90e-05	2	152	2	16914570
Pubmed	The leukemia-specific fusion gene ETV6/RUNX1 perturbs distinct key biological functions primarily by gene repression.	ETV6 RUNX1	1.90e-05	2	152	2	22028862
Pubmed	Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse.	MAPT KANSL1	1.90e-05	2	152	2	21492964
Pubmed	Low Frequency of ETV6-RUNX1 (t 12; 21) in Saudi Arabian Pediatric Acute Lymphoblastic Leukemia Patients: Association with Clinical Parameters and Early Remission.	ETV6 RUNX1	1.90e-05	2	152	2	26625756
Pubmed	Clock gene Per3 deficiency disrupts circadian alterations of gut microbiota in mice.	CLOCK PER3	1.90e-05	2	152	2	37964605
Pubmed	Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse.	ETV6 RUNX1	1.90e-05	2	152	2	28418909
Pubmed	ETV6/RUNX1 fusion lacking prognostic effect in pediatric patients with acute lymphoblastic leukemia.	ETV6 RUNX1	1.90e-05	2	152	2	19100516
Pubmed	Do Caucasian and Asian clocks tick differently?	CLOCK PER3	1.90e-05	2	152	2	19967263
Pubmed	Prevalence of ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia in China.	ETV6 RUNX1	1.90e-05	2	152	2	17889709
Pubmed	Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins.	ETV6 RUNX1	1.90e-05	2	152	2	25388957
Pubmed	Cytogenetic patterns in ETV6/RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia: A Nordic series of 245 cases and review of the literature.	ETV6 RUNX1	1.90e-05	2	152	2	17285576
Pubmed	Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.	ETV6 RUNX1	1.90e-05	2	152	2	15104290
Pubmed	RAG-dependent recombination at cryptic RSSs within TEL-AML1 t(12;21)(p13;q22) chromosomal translocation region.	ETV6 RUNX1	1.90e-05	2	152	2	21029724
Pubmed	ETV6/RUNX1-positive childhood acute lymphoblastic leukemia (ALL): The spectrum of clonal heterogeneity and its impact on prognosis.	ETV6 RUNX1	1.90e-05	2	152	2	29778230
Pubmed	Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.	ETV6 RUNX1	1.90e-05	2	152	2	18202291
Pubmed	Cytoskeletal regulatory gene expression and migratory properties of B-cell progenitors are affected by the ETV6-RUNX1 rearrangement.	ETV6 RUNX1	1.90e-05	2	152	2	25061103
Pubmed	Amphiphysin-1 protein level changes associated with tau-mediated neurodegeneration.	AMPH MAPT	1.90e-05	2	152	2	22975846
Pubmed	Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity.	CLOCK RAI1	1.90e-05	2	152	2	22578325
Pubmed	Outcome and Prognostic Factors for ETV6/RUNX1 Positive Pediatric Acute Lymphoblastic Leukemia Treated at a Single Institution in Korea.	ETV6 RUNX1	1.90e-05	2	152	2	27506214
Pubmed	Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons.	MAPT KANSL1	1.90e-05	2	152	2	26459111
Pubmed	Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis.	ETV6 RUNX1	1.90e-05	2	152	2	15142881
Pubmed	Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemia.	ETV6 RUNX1	1.90e-05	2	152	2	16307024
Pubmed	ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells.	ETV6 RUNX1	1.90e-05	2	152	2	24339741
Pubmed	Circadian rhythm genes CLOCK and PER3 polymorphisms and morning gastric motility in humans.	CLOCK PER3	1.90e-05	2	152	2	25775462
Pubmed	Streamlined platform for short hairpin RNA interference and transgenesis in cultured mammalian cells.	PTBP2 PTBP1	1.90e-05	2	152	2	21768390
Pubmed	Fishing for ETV6/RUNX1 fusion and MLL gene rearrangements and their additional abnormalities in childhood acute lymphoblastic leukemia patients of Kashmir.	ETV6 RUNX1	1.90e-05	2	152	2	36565795
Pubmed	Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model.	ETV6 RUNX1	1.90e-05	2	152	2	34019812
Pubmed	TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.	ETV6 RUNX1	1.90e-05	2	152	2	18635414
Pubmed	Effects of Occupational Stress and Circadian CLOCK Gene Polymorphism on Sleep Quality of Oil Workers in Xinjiang, China.	CLOCK PER3	1.90e-05	2	152	2	32737280
Pubmed	ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications.	ETV6 RUNX1	1.90e-05	2	152	2	15704129
Pubmed	TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia.	ETV6 RUNX1	1.90e-05	2	152	2	12526921
Pubmed	Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.	ETV6 RUNX1	1.90e-05	2	152	2	18445843
Pubmed	Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials.	ETV6 RUNX1	1.90e-05	2	152	2	29064485
Pubmed	Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche.	ETV6 RUNX1	1.90e-05	2	152	2	32118299
Pubmed	[Prognostic significance of TEL/AML1 rearrangement and its additional genetic changes in Korean childhood precursor B-acute lymphoblastic leukemia].	ETV6 RUNX1	1.90e-05	2	152	2	20197715
Pubmed	The association of CLOCK gene T3111C polymorphism and hPER3 gene 54-nucleotide repeat polymorphism with Chinese Han people schizophrenics.	CLOCK PER3	1.90e-05	2	152	2	20364331
Pubmed	ETV6/RUNX1 Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia.	ETV6 RUNX1	1.90e-05	2	152	2	31952221
Pubmed	Alternative splicing of brain-specific PTB defines a tissue-specific isoform pattern that predicts distinct functional roles.	PTBP2 PTBP1	1.90e-05	2	152	2	12213192
Pubmed	Genome-wide analysis of cytogenetic aberrations in ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia.	ETV6 RUNX1	1.90e-05	2	152	2	22404039
Pubmed	Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia.	ETV6 RUNX1	1.90e-05	2	152	2	17956600
Pubmed	PTBP1 and PTBP2 Repress Nonconserved Cryptic Exons.	PTBP2 PTBP1	1.90e-05	2	152	2	27681424
Pubmed	A genomic sequence analysis of the mouse and human microtubule-associated protein tau.	MAPT KANSL1	1.90e-05	2	152	2	11641718
Pubmed	Par-3 family proteins in cell polarity & adhesion.	PARD3B PARD3	1.90e-05	2	152	2	33565714
Pubmed	Transcript-specific characteristics determine the contribution of endo- and exonucleolytic decay pathways during the degradation of nonsense-mediated decay substrates.	SMG7 SMG6	1.90e-05	2	152	2	28461625
Pubmed	TELAML1-positive ALL: a discordant genotype.	ETV6 RUNX1	1.90e-05	2	152	2	15970674
Pubmed	ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy.	ETV6 RUNX1	1.90e-05	2	152	2	21869842
Pubmed	Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.	ETV6 RUNX1	1.90e-05	2	152	2	18928518
Pubmed	A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1.	ETV6 RUNX1	1.90e-05	2	152	2	29290585
Pubmed	Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.	ETV6 RUNX1	1.90e-05	2	152	2	7761424
Pubmed	Human polypyrimidine tract-binding protein interacts with mitochondrial tRNA(Thr) in the cytosol.	PTBP3 PTBP2	1.90e-05	2	152	2	26657638
Pubmed	Cytogenetics of long-term survivors of ETV6-RUNX1 fusion positive acute lymphoblastic leukemia.	ETV6 RUNX1	1.90e-05	2	152	2	19998443
Pubmed	Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.	ETV6 RUNX1	1.90e-05	2	152	2	16278392
Pubmed	Clock genes associate with white matter integrity in depressed bipolar patients.	CLOCK PER3	1.90e-05	2	152	2	27996307
Pubmed	The Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens.	TNFRSF25 TNFRSF1B	1.90e-05	2	152	2	32397343
Pubmed	Identification of diagnosis and prognosis gene markers in B-ALL with ETV6-RUNX1 fusion by integrated bioinformatics analysis.	ETV6 RUNX1	1.90e-05	2	152	2	34999180
Pubmed	Clock 3111 T/C and Period3 VNTR gene polymorphisms and proteins, and melatonin levels in women with infertility.	CLOCK PER3	1.90e-05	2	152	2	36847953
Pubmed	TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemia.	ETV6 RUNX1	1.90e-05	2	152	2	19570513
Pubmed	Mechanism of ETV6-RUNX1 Leukemia.	ETV6 RUNX1	1.90e-05	2	152	2	28299659
Pubmed	ETV6-RUNX1 + Acute Lymphoblastic Leukaemia in Identical Twins.	ETV6 RUNX1	1.90e-05	2	152	2	28299660
Pubmed	TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia.	ETV6 RUNX1	1.90e-05	2	152	2	17015828
Pubmed	Transcriptome-wide identification of NMD-targeted human mRNAs reveals extensive redundancy between SMG6- and SMG7-mediated degradation pathways.	SMG7 SMG6	1.90e-05	2	152	2	27864472
Interaction	YWHAH interactions	STIM2 MAPT MARK3 PARD3B TBC1D25 SRGAP2 GIT2 ATXN1L MICALL1 PIK3R4 TBC1D10B NFATC3 CSNK1D KIAA1217 SIPA1L1 NAV2 MAST1 AKAP11 SSH2 PARD3 RIMS2 SRRM2 PLEKHA7 CAMSAP2 RGL2 PRRC1	1.37e-07	1102	149	26	int:YWHAH
Interaction	GSC interactions	SOX5 BCL9 ATXN1L KMT2C ARID1B AUTS2 FOXP1 SMAD2	2.64e-07	87	149	8	int:GSC
Interaction	DCLK1 interactions	STARD13 MAPT TBC1D25 SRGAP2 SHANK3 SIPA1L1 PLEKHA7 CAMSAP2 AGAP2	4.37e-07	127	149	9	int:DCLK1
Interaction	YWHAE interactions	STIM2 ACD MAPT MARK3 CHAF1A PARD3B TACC2 SRGAP2 GIT2 SHANK3 LRCH3 MICALL1 PIK3R4 HAVCR1 SIPA1L1 NAV2 MAST1 AKAP11 ASXL2 SSH2 PARD3 RIMS2 SRRM2 PLEKHA7 CAMSAP2 RGL2 AGRN	4.83e-07	1256	149	27	int:YWHAE
Interaction	SOX2 interactions	SOX3 SOX5 PTBP3 PCNX3 PTBP2 MARK3 GLIS3 ETV6 TUT1 ZNF362 PTBP1 RUNX1 BCL9 ATXN1L CLOCK AHDC1 HOXA5 KMT2C ARID1B KIAA1217 SIPA1L1 MSL3 NAV2 FOXP1 AKAP11 CNOT3 PRRC1 SMG6	1.64e-06	1422	149	28	int:SOX2
Interaction	RAPGEF4 interactions	PCLO SRGAP2 SHANK3 ZC3H11A RIMS2 AGAP2	1.79e-06	50	149	6	int:RAPGEF4
Interaction	TLE3 interactions	ETV6 ZNF362 RUNX1 BCL9 ATXN1L CLOCK AHDC1 ARID1B POM121 SMG7 AUTS2 ASXL2 SRRM2	4.58e-06	376	149	13	int:TLE3
Interaction	YWHAB interactions	STIM2 MAPT MARK3 CHAF1A PARD3B SRGAP2 SHANK3 MICALL1 PIK3R4 TBC1D10B NFATC3 SIPA1L1 NAV2 MAST1 AKAP11 SSH2 PARD3 SRRM2 PLEKHA7 CAMSAP2 RGL2 AGAP2	5.52e-06	1014	149	22	int:YWHAB
Interaction	KSR1 interactions	STARD13 MARK3 TBC1D25 SRGAP2 MICALL1 SIPA1L1 PLEKHA7 CAMSAP2	6.28e-06	132	149	8	int:KSR1
Interaction	MAPRE3 interactions	STIM2 LHX4 MAPT MARK3 TACC2 PIK3R4 KIAA1217 NAV2 TMEM131 CAMSAP2	8.44e-06	230	149	10	int:MAPRE3
Interaction	GSK3A interactions	MAPT PTBP2 MARK3 ATG2B PTBP1 RUNX1 AHDC1 PRUNE1 SMG7 SIPA1L1 AKAP11 SRRM2 CAMSAP2 SMAD2	9.26e-06	464	149	14	int:GSK3A
Interaction	HNF1B interactions	SOX5 LHX4 BCL9 ATXN1L KMT2C ARID1B SUDS3 FOXP1 ASXL2	1.22e-05	190	149	9	int:HNF1B
Interaction	GJA1 interactions	STIM2 PCNX3 AVPR2 MARK3 GPR182 NIBAN2 KCNB2 SLC4A2 GGA3 PIK3R4 RGS14 CSNK1D KIAA1217 PARD3 PLEKHA7	2.86e-05	583	149	15	int:GJA1
Interaction	AFDN interactions	MAPT MARK3 TBC1D25 SRGAP2 NIBAN2 KCNB2 KIAA1217 SIPA1L1 PARD3 PLEKHA7 SMAD2	3.86e-05	333	149	11	int:AFDN
Interaction	YWHAG interactions	STIM2 MAPT MARK3 CHAF1A PARD3B SRGAP2 GIT2 SHANK3 LRCH3 MICALL1 PIK3R4 TBC1D10B NFATC3 SIPA1L1 NAV2 AKAP11 SSH2 PARD3 SRRM2 PLEKHA7 CAMSAP2 RGL2 PRRC1	4.50e-05	1248	149	23	int:YWHAG
Interaction	SH3PXD2A interactions	STARD13 MARK3 TBC1D25 SRGAP2 SIPA1L1 PLEKHA7 CAMSAP2	4.70e-05	128	149	7	int:SH3PXD2A
Interaction	FLOT1 interactions	SOX5 LHX4 INCENP MARK3 PCLO ETV6 NIBAN2 KCNB2 NFATC3 KIAA1217 PARD3 PLEKHA7 SMAD2	5.36e-05	475	149	13	int:FLOT1
Interaction	LHX3 interactions	SOX5 BCL9 ATXN1L KMT2C ARID1B SUDS3 FOXP1 ZNF574	7.17e-05	185	149	8	int:LHX3
Interaction	SOX17 interactions	BCL9 ATXN1L HOXA5 KMT2C ARID1B SUDS3	7.47e-05	95	149	6	int:SOX17
Interaction	TOP3B interactions	SPHK2 PCNX3 RBM33 TBC1D25 SRGAP2 LRRK1 BCL9 STK11IP AHDC1 GGA3 MICALL1 HIVEP3 KMT2C ZC3H11A KANSL1 SMG7 TMEM259 XPO6 NAV2 SLC45A1 SNAPC4 RGL2 AGRN RAI1 SMG6	7.50e-05	1470	149	25	int:TOP3B
Interaction	TESK2 interactions	STARD13 TBC1D25 SRGAP2 SIPA1L1 PLEKHA7 CAMSAP2	8.39e-05	97	149	6	int:TESK2
Interaction	NFIB interactions	SOX5 LHX4 BCL9 ATXN1L KMT2C ARID1B FOXP1	9.06e-05	142	149	7	int:NFIB
Interaction	KIF13B interactions	STARD13 TBC1D25 SRGAP2 MICALL1 SIPA1L1 PLEKHA7 CAMSAP2	9.06e-05	142	149	7	int:KIF13B
Interaction	SYNGAP1 interactions	STARD13 AMPH MAPT SRGAP2 KCNB2 SHANK3 RGS14 SIPA1L1 CAMSAP2 AGAP2	9.83e-05	307	149	10	int:SYNGAP1
Interaction	DENND1A interactions	STARD13 TBC1D25 SRGAP2 SIPA1L1 PLEKHA7 CAMSAP2	1.05e-04	101	149	6	int:DENND1A
Interaction	ZNF609 interactions	SOX5 LHX4 LHX8 KANSL1 SMG7 SUDS3 AUTS2	1.08e-04	146	149	7	int:ZNF609
Interaction	MAGI1 interactions	STARD13 TBC1D25 SRGAP2 SIPA1L1 PARD3 PLEKHA7 CAMSAP2	1.13e-04	147	149	7	int:MAGI1
Interaction	CRX interactions	SOX3 SOX5 BCL9 ATXN1L KMT2C ARID1B FOXP1 ASXL2 RAI1	1.17e-04	254	149	9	int:CRX
Interaction	INPP5E interactions	STARD13 SRGAP2 SIPA1L1 PLEKHA7 CAMSAP2	1.19e-04	65	149	5	int:INPP5E
Interaction	ANK3 interactions	MAPT SHANK3 LRCH3 RGS14 KIAA1217 AGRN SMAD2 AGAP2	1.28e-04	201	149	8	int:ANK3
Interaction	FEV interactions	SOX5 BCL9 ATXN1L KMT2C ARID1B SUDS3 FOXP1 ASXL2	1.37e-04	203	149	8	int:FEV
Interaction	FAM110B interactions	TBC1D25 SRGAP2 CSNK1D SIPA1L1 PLEKHA7	1.38e-04	67	149	5	int:FAM110B
Interaction	GCM1 interactions	BCL9 ATXN1L KMT2C ARID1B FOXP1	1.48e-04	68	149	5	int:GCM1
Interaction	PCLO interactions	PCLO GIT2 RGS14 RIMS2 AGAP2	1.70e-04	70	149	5	int:PCLO
Interaction	RASAL2 interactions	SRGAP2 CSNK1D SIPA1L1 PARD3 PLEKHA7 CAMSAP2 AGAP2	1.76e-04	158	149	7	int:RASAL2
Interaction	PTBP2 interactions	PTBP3 MAPT PTBP2 PTBP1 CAMSAP2	1.94e-04	72	149	5	int:PTBP2
Interaction	ZBTB21 interactions	STARD13 TBC1D25 SRGAP2 MICALL1 SIPA1L1 PLEKHA7 CAMSAP2	1.98e-04	161	149	7	int:ZBTB21
Interaction	RIMS1 interactions	CACNA1B MAPT LRRK1 AGAP2	2.13e-04	40	149	4	int:RIMS1
Interaction	AGAP1 interactions	GRB7 TBC1D25 SRGAP2 SIPA1L1 PLEKHA7 CAMSAP2	2.35e-04	117	149	6	int:AGAP1
Interaction	DYRK1A interactions	TNFRSF25 AMPH MAPT LRCH3 GGA3 POM121 MEGF9 KIAA1217 SIPA1L1 AKAP11 CAMSAP2 CNOT3 SMAD2	2.38e-04	552	149	13	int:DYRK1A
Interaction	EGR2 interactions	SOX5 BCL9 ATXN1L AHDC1 KMT2C ARID1B FOXP1	2.86e-04	171	149	7	int:EGR2
Interaction	PPM1H interactions	STARD13 TBC1D25 SRGAP2 SIPA1L1 PLEKHA7 CAMSAP2	3.08e-04	123	149	6	int:PPM1H
Interaction	SIPA1L1 interactions	STARD13 TBC1D25 SRGAP2 SIPA1L1 PARD3 PLEKHA7 CAMSAP2	3.18e-04	174	149	7	int:SIPA1L1
Interaction	LRFN1 interactions	STARD13 TBC1D25 SRGAP2 SIPA1L1 PLEKHA7 CAMSAP2	3.22e-04	124	149	6	int:LRFN1
Interaction	PAX7 interactions	BCL9 ATXN1L KMT2C ARID1B SUDS3 FOXP1	3.22e-04	124	149	6	int:PAX7
Interaction	NUP35 interactions	RBM33 GLIS3 BCL9 AHDC1 HIVEP3 KMT2C ARID1B POM121 SMG7 AUTS2 RAI1	3.23e-04	424	149	11	int:NUP35
Interaction	TLX1 interactions	BCL9 ATXN1L KMT2C ARID1B AUTS2 FOXP1 ASXL2	3.29e-04	175	149	7	int:TLX1
Interaction	RNF43 interactions	STIM2 RBM33 PTBP1 KCNB2 GGA3 POM121 SMG7 KIAA1217 TMEM131 PARD3 PLEKHA7	3.42e-04	427	149	11	int:RNF43
Interaction	GIGYF1 interactions	STARD13 GRB7 TBC1D25 SRGAP2 SIPA1L1 PLEKHA7 CAMSAP2	3.52e-04	177	149	7	int:GIGYF1
GeneFamily	PDZ domain containing	PCLO PARD3B SHANK3 SHROOM4 SIPA1L1 MAST1 PARD3 RIMS2	1.59e-06	152	97	8	1220
GeneFamily	Non-canonical poly(A) polymerases	TENT4A TUT1	5.88e-04	7	97	2	1318
GeneFamily	ArfGAPs	GIT2 AGAP11 AGAP2	7.27e-04	33	97	3	395
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PSD GRB7 PLEKHA7 SKAP2 AGAP2 SOS2	8.50e-04	206	97	6	682
GeneFamily	LIM class homeoboxes	LHX4 LHX8	1.82e-03	12	97	2	522
GeneFamily	X-linked mental retardation\|Rho GTPase activating proteins\|BAR-PH domain containing	AGAP11 AGAP2	3.68e-03	17	97	2	1291
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	PRDM2 PRDM12	3.68e-03	17	97	2	1197
GeneFamily	SRY-boxes	SOX3 SOX5	4.59e-03	19	97	2	757
Coexpression	ZHONG_PFC_C3_ASTROCYTE	CACNA1B PSD ACD RBM33 PCLO ZNF362 STK11IP PRDM2 KIAA0319 AUTS2 MAST1 TMEM131 SLC45A1 SNAPC4 AGAP2	8.25e-09	389	151	15	M39102
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN	USP36 TNFRSF25 SPHK2 RBM33 NIBAN2 GIT2 ATXN1L BHLHE40 LRCH3 GGA3 CSNK1D XPO6 MAP4K1 TMEM131 SRRM2 MNDA RAI1	1.62e-07	634	151	17	M40866
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	USP36 TNFRSF25 SPHK2 RBM33 IL18BP ZNF362 NIBAN2 GIT2 ATXN1L BHLHE40 GGA3 TMEM259 CSNK1D XPO6 MAP4K1 TMEM131 TNFRSF1B SRRM2 MNDA RAI1	2.76e-07	905	151	20	M40865
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	PTBP3 TNFRSF25 STIM2 RBM33 MARK3 CHD2 GIT2 FHIP2A BHLHE40 ZAP70 PRDM2 HIVEP3 RGS14 KMT2C ZC3H11A KANSL1 NFATC3 XPO6 MAP4K1 AUTS2 AKAP11 ASXL2 ELK4 SSH2 TNFRSF1B	1.42e-06	1492	151	25	M40023
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	STARD13 AMPH MARK3 SRGAP2 RUNX1 CLOCK BHLHE40 AHDC1 PIK3R4 NFATC3 XPO6 SIPA1L1 AKAP11 TMEM131 PARD3 SKAP2 CAMSAP2 SOS2	2.31e-06	856	151	18	M4500
Coexpression	GSE14350_TREG_VS_TEFF_UP	STIM2 ATXN1L CLOCK ARID1B MEGF9 TMEM131 ASXL2 SSH2 TNFRSF1B	2.44e-06	199	151	9	M3417
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	SPHK2 RBM33 IL18BP PTBP1 MICALL1 SMG7 TMEM259 SNAPC4 SRRM2 AGRN CNOT3	4.50e-06	338	151	11	M17094
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	SRGAP2 AASDH FHIP2A PRDM2 NAV2 ASXL2 ELK4 SNAPC4	5.63e-06	166	151	8	M6826
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	IL18BP CLOCK PRDM2 FOXP1 AKAP11 SNAPC4 SKAP2	1.99e-05	143	151	7	M9149
Coexpression	GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN	PCNX3 CAMTA2 KMT2C NFATC3 SNAPC4 RGL2 RAI1 ZNF574	2.11e-05	199	151	8	M9443
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	VGF PTBP3 STIM2 PSD RBM33 PCLO AHDC1 SHANK3 PRDM2 HIVEP3 MEGF9 AUTS2 MAST1 ZFHX2 KIF3C SSH2 RIMS2 CAMSAP2 RAI1	2.11e-05	1106	151	19	M39071
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL	VGF TNFRSF25 AMPH PSD PCLO TUT1 PPP1R1A MEGF9 MAST1 ZFHX2 RIMS2	4.10e-05	429	151	11	M45694
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN	USP36 TNFRSF25 TENT4A RBM33 PTBP2 CHD2 FHIP2A ATXN1L BHLHE40 PRDM2 MAP4K1	4.37e-05	432	151	11	M41149
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	GLIS3 ETV6 RUNX1 TENM4 FOXP1 RIMS2 PLEKHA7	5.79e-05	169	151	7	M39230
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	GLIS3 PARD3B KANSL1 KIAA1217 SIPA1L1 SSH2 PARD3	7.48e-05	176	151	7	M39223
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	STARD13 STIM2 CHD2 GIT2 RUNX1 FHIP2A SLC4A2 SUDS3 KIAA1217 SIPA1L1 KANK4 NAV2 AUTS2 PRDM12 FOXP1 SSH2 PARD3	7.51e-05	1009	151	17	M157
Coexpression	GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP	RBM33 FHIP2A STK11IP HAVCR1 KANSL1 SSH2 AGAP2	1.61e-04	199	151	7	M5709
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	USP36 RBM33 PTBP2 DHRS13 TBC1D25 CHD2 BHLHE40 PRDM2 POM121 CSNK1D SIPA1L1 FOXP1 ELK4	1.63e-04	680	151	13	M41089
Coexpression	GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP	PTBP3 TNFRSF25 ZNF362 BCL9 HOXA5 CSNK1D SMAD2	1.66e-04	200	151	7	M7086
Coexpression	GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN	STIM2 BCL9 HIVEP3 KMT2C TBC1D10B SUDS3 SIPA1L1	1.66e-04	200	151	7	M3510
Coexpression	GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN	STIM2 NR1H3 TUT1 BCL9 SUDS3 SIPA1L1 KIF3C	1.66e-04	200	151	7	M3513
Coexpression	GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_DN	SOX5 BHLHE40 GHRH TENM4 PER3 KIAA1217 PRRC1	1.66e-04	200	151	7	M9607
Coexpression	GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP	RBM33 TUT1 CAMTA2 MAP4K1 RGL2 AGRN SMAD2	1.66e-04	200	151	7	M6004
Coexpression	GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP	CAMTA2 ZNF362 BCL9 RGS14 MRTFB XPO6 RGL2	1.66e-04	200	151	7	M5069
Coexpression	GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP	SPHK2 CAMTA2 GIT2 GGA3 RGS14 POM121 MEGF9	1.66e-04	200	151	7	M5154
Coexpression	GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN	TUT1 NIBAN2 CLOCK SLC4A2 TMEM259 ELK4 RGL2	1.66e-04	200	151	7	M4354
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL	AMPH PSD PCLO TACC2 KCNB2 PPP1R1A HIVEP3 RIMS2	1.70e-04	268	151	8	M45696
Coexpression	HALLMARK_UV_RESPONSE_DN	AMPH TENT4A RUNX1 BHLHE40 PRDM2 SIPA1L1	1.92e-04	144	151	6	M5942
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	STARD13 SOX5 GLIS3 PARD3B ARID1B KANSL1 SIPA1L1 NAV2 AUTS2 PARD3 PLEKHA7	8.52e-11	198	151	11	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	STARD13 SOX5 PTBP2 ETV6 PARD3B KMT2C ARID1B KANSL1 AUTS2 SSH2 PARD3	8.99e-11	199	151	11	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	STARD13 SOX5 PARD3B HIVEP3 ARID1B KANSL1 SIPA1L1 NAV2 AUTS2 PARD3	1.44e-09	196	151	10	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ETV6 RUNX1 KMT2C ARID1B KANSL1 SIPA1L1 FOXP1 SSH2 PLEKHA7	2.13e-08	193	151	9	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	SOX5 PARD3B TACC2 KIAA1217 NAV2 AUTS2 PARD3 PLEKHA7	3.13e-07	192	151	8	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	GLIS3 PARD3B ARID1B SIPA1L1 FOXP1 SSH2 PARD3 PLEKHA7	3.13e-07	192	151	8	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	Mild/Remission-B_intermediate-14\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SOX5 LHX4 DCST2 AHDC1 SHROOM4 CPXM1 MNDA	3.83e-07	134	151	7	5bd1e3fa6278facd9e949e9e5e244e700190126b
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VGF PRR36 GLIS3 KCNB2 PPP1R1A SLC45A1 RIMS2	2.21e-06	174	151	7	a62531ebf16b32b249168dca11b870f63a8aa81c
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	CHD2 PRDM2 KMT2C ARID1B KANSL1 TMEM131 SMG6	3.69e-06	188	151	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	IPF-Epithelial-Club\|IPF / Disease state, Lineage and Cell class	SOX5 GLIS3 PARD3B TACC2 KIAA1217 NAV2 PARD3	3.83e-06	189	151	7	f3fcef008ef252b29ac6d567fef27f9acf9cd70f
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	SOX5 GLIS3 PARD3B TACC2 KIAA1217 NAV2 PARD3	4.70e-06	195	151	7	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	Control-Multiplet\|Control / Disease state, Lineage and Cell class	SOX5 GLIS3 TACC2 KIAA1217 NAV2 AUTS2 PARD3	4.70e-06	195	151	7	618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	SOX5 GLIS3 PARD3B TACC2 KIAA1217 NAV2 PARD3	4.70e-06	195	151	7	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	Control-Multiplet-Multiplet\|Control / Disease state, Lineage and Cell class	SOX5 GLIS3 TACC2 KIAA1217 NAV2 AUTS2 PARD3	4.70e-06	195	151	7	06ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RBM33 CHD2 PRDM2 KMT2C ARID1B KANSL1 SRRM2	5.55e-06	200	151	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	BHLHE40 ARID1B KANSL1 TMEM259 CSNK1D TNFRSF1B SRRM2	5.55e-06	200	151	7	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	Mild/Remission-B_intermediate-14\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SOX5 DCST2 AHDC1 SHROOM4 CPXM1 MNDA	8.73e-06	141	151	6	69e32125a0e8f0c8561e5e7a93607f368f09546f
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PTBP2 CHAF1A NR1H3 NIBAN2 PIK3R4 XPO6	2.36e-05	168	151	6	94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TNFRSF25 INCENP TBC1D25 BHLHE40 ZAP70 ZC3H11A	2.36e-05	168	151	6	a7eb28e15b591997f1aee09501cb20ae18beca08
ToppCell	5'-Adult-SmallIntestine-Epithelial-neuro-epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VGF PSD KCNB2 PPP1R1A GHRH RIMS2	2.78e-05	173	151	6	30fa8c14c8a1f546f380132c0c28a61e6a2f9fc4
ToppCell	RSV-Healthy-1\|Healthy / Virus stimulation, Condition and Cluster	LHX4 IL18BP NFATC3 SLC45A1 MNDA AGAP2	2.97e-05	175	151	6	ff3a27f512a3a710ebc863b7b75cce8167d5440b
ToppCell	RSV-Healthy-1\|RSV / Virus stimulation, Condition and Cluster	LHX4 IL18BP NFATC3 SLC45A1 MNDA AGAP2	2.97e-05	175	151	6	ca52b99b03535a5b3a2751d6981708dc5b255b91
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KCNB2 HIVEP3 TENM4 NAV2 PARD3 RIMS2	3.26e-05	178	151	6	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	renal_papilla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 SOX5 PTBP3 KIAA1217 AUTS2 SLC14A2	3.48e-05	180	151	6	49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	GLIS3 TACC2 NIBAN2 KIAA1217 NAV2 PARD3	3.58e-05	181	151	6	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TACC2 KCNB2 BHLHE40 PPP1R1A FNDC1 RIMS2	3.81e-05	183	151	6	a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	GLIS3 TACC2 KIAA1217 NAV2 PARD3 PLEKHA7	4.05e-05	185	151	6	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	SOX5 GLIS3 PARD3B NAV2 AUTS2 PARD3	4.05e-05	185	151	6	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	COPD-Epithelial-Club\|World / Disease state, Lineage and Cell class	GLIS3 PARD3B TACC2 KIAA1217 NAV2 PARD3	4.17e-05	186	151	6	3006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 PTBP3 STIM2 GLIS3 BHLHE40 SLC14A2	4.43e-05	188	151	6	4154f4787483c7e076e87a187733a9f666742c3d
ToppCell	MS-CD8-antiviral_CD4\|MS / Condition, Cell_class and T cell subcluster	ZNF362 STK11IP BHLHE40 TBC1D10B PRRC1 ZNF574	4.70e-05	190	151	6	8c831c4560b8e70f92b4c15644fea39f7f7afcf2
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	SOX5 GLIS3 TACC2 KIAA1217 NAV2 PARD3	4.84e-05	191	151	6	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 SOX5 PTBP3 STIM2 GLIS3 BHLHE40	4.84e-05	191	151	6	96b78b4e819ea6052334bfcbc7abbf35897df885
ToppCell	COPD-Epithelial\|COPD / Disease state, Lineage and Cell class	SOX5 GLIS3 TACC2 KIAA1217 NAV2 PARD3	4.98e-05	192	151	6	0644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	USP36 CHD2 ZAP70 KMT2C KANSL1 FOXP1	4.98e-05	192	151	6	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	Fibroblasts-CD55+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	SOX5 TACC2 PPP1R1A SSC5D AUTS2 SLC45A1	5.12e-05	193	151	6	8f4bf9a2fbedae35432dad96730b00c70185874c
ToppCell	Children_(3_yrs)-Immune-monocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ETV6 SRGAP2 LRRK1 TNFRSF1B SKAP2 MNDA	5.12e-05	193	151	6	58e1930a1d80ad3729ab9604ac8ebf7308232a3d
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STIM2 SRGAP2 SHANK3 SHROOM4 MRTFB KIAA1217	5.12e-05	193	151	6	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STIM2 SRGAP2 SHANK3 SHROOM4 MRTFB KIAA1217	5.12e-05	193	151	6	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STIM2 SRGAP2 SHANK3 SHROOM4 MRTFB KIAA1217	5.12e-05	193	151	6	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PCLO GLIS3 PARD3B TACC2 PARD3 PLEKHA7	5.12e-05	193	151	6	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	RBM33 PTBP2 PARD3B ARID1B KANSL1 SRRM2	5.12e-05	193	151	6	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	VGF CACNA1B PCLO MAST1 AKAP11 SLC45A1	5.27e-05	194	151	6	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	SOX5 GLIS3 TACC2 KIAA1217 NAV2 PARD3	5.43e-05	195	151	6	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1B AMPH PCLO KCNB2 MRTFB RIMS2	5.58e-05	196	151	6	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	COVID-19-Myeloid-Monocytes\|COVID-19 / group, cell type (main and fine annotations)	ETV6 MEGF9 SIPA1L1 SSH2 TNFRSF1B MNDA	5.58e-05	196	151	6	04d710267658ea5601ae2cfb4ed5acb8a29bd8a1
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PCDHGB6 PCLO KCNB2 PPP1R1A MAST1 RIMS2	5.74e-05	197	151	6	ff4df77117165b6b25315e29b0722cc136eba607
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	BHLHE40 KMT2C ARID1B KANSL1 CSNK1D SRRM2	5.74e-05	197	151	6	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1B AMPH PCLO MRTFB TENM4 RIMS2	5.91e-05	198	151	6	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Severe-B_intermediate-6\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SOX5 BHLHE40 MAP4K1 ELK4 TNFRSF1B MNDA	6.07e-05	199	151	6	bf6ebb63ab361d9d1946225894d7be433e9befab
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	CACNA1B AMPH PCLO KCNB2 MRTFB RIMS2	6.24e-05	200	151	6	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_T_naive\|Influenza_Severe / Disease, condition lineage and cell class	USP36 TNFRSF25 B3GNT9 DCST2 SHROOM4 FOXP1	6.24e-05	200	151	6	0382f8fc27d18003761725e714beb6b3f3150057
Drug	Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; HL60; HT_HG-U133A	PTBP3 SPHK2 INCENP RUNX1 GGA3 MICALL1 MRTFB PRDM12 ZFHX2 SRRM2 SOS2	6.99e-08	193	151	11	2412_UP
Drug	Epivincamine [6835-99-0]; Down 200; 11.2uM; PC3; HT_HG-U133A	PTBP3 TNFRSF25 MAPT GRB7 GGA3 CNNM4 PER3 TMEM259 MSL3 SOS2	7.78e-07	196	151	10	4500_DN
Drug	Thiamphenicol [15318-45-3]; Up 200; 11.2uM; HL60; HT_HG-U133A	PTBP3 SPHK2 INCENP RUNX1 MICALL1 SMG7 MSL3 ZFHX2 CAMSAP2 SOS2	7.78e-07	196	151	10	1867_UP
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A	GRB7 ETV6 TUT1 RUNX1 PRDM2 HIVEP3 RGS14 RIMS2 SMG6 SOS2	7.78e-07	196	151	10	3816_DN
Drug	Josamycin [16846-24-5]; Down 200; 4.8uM; PC3; HT_HG-U133A	SPHK2 MAPT LRRK1 RUNX1 CNNM4 SMG7 PER3 TMEM259 SNAPC4 SOS2	8.15e-07	197	151	10	4631_DN
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	PTBP3 SPHK2 GRB7 ETV6 CAMTA2 RUNX1 HIVEP3 NFATC3 SMG6 SOS2	8.53e-07	198	151	10	6812_UP
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	TACC2 PIK3R4 MRTFB TENM4 SIPA1L1 NAV2 PARD3 CAMSAP2 SOS2	2.18e-06	171	151	9	7535_DN
Drug	Probenecid [57-66-9]; Down 200; 14uM; HL60; HT_HG-U133A	PTBP3 INCENP BHLHE40 PRDM2 RGS14 NFATC3 CAMSAP2 ZNF574 SOS2	6.39e-06	195	151	9	2464_DN
Drug	Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A	PRR36 GIT2 BCL9 BHLHE40 HIVEP3 SIPA1L1 NAV2 RIMS2 ZNF574	6.39e-06	195	151	9	3478_UP
Drug	Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; PC3; HT_HG-U133A	PTBP3 TNFRSF25 ZNF362 GIT2 RUNX1 RGS14 MSL3 ELK4 CNOT3	6.66e-06	196	151	9	5749_DN
Drug	Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; PC3; HT_HG-U133A	VGF TNFRSF25 CAMTA2 LRRK1 RUNX1 CNNM4 RGS14 ELK4 SOS2	6.66e-06	196	151	9	5091_DN
Drug	Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	TNFRSF25 CHAF1A RUNX1 SLC4A2 SMG7 SIPA1L1 ZFHX2 SMG6 SOS2	6.66e-06	196	151	9	3327_DN
Drug	Colistin sulfate [1264-72-8]; Up 200; 3uM; MCF7; HT_HG-U133A	PTBP3 ETV6 GIT2 PRUNE1 CNNM4 RGS14 PER3 ZFHX2 RIMS2	6.93e-06	197	151	9	4796_UP
Drug	Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; PC3; HT_HG-U133A	STARD13 INCENP PTBP2 TACC2 SRGAP2 CAMTA2 GIT2 TBC1D10B ELK4	6.93e-06	197	151	9	7138_DN
Drug	PF-00539745-00 [351321-33-0]; Down 200; 10uM; PC3; HT_HG-U133A	VGF PTBP1 RUNX1 PRDM2 HIVEP3 CNNM4 PRDM12 ELK4 SOS2	6.93e-06	197	151	9	5939_DN
Drug	Demecarium bromide [56-94-0]; Down 200; 5.6uM; MCF7; HT_HG-U133A	SOX3 MAPT GIT2 PRUNE1 SMG7 NFATC3 MSL3 KIF3C SNAPC4	7.22e-06	198	151	9	6269_DN
Drug	cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Down 200; 100uM; PC3; HG-U133A	VGF PTBP3 TNFRSF25 TUT1 SRGAP2 RUNX1 BHLHE40 AGRN SOS2	7.22e-06	198	151	9	664_DN
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; PC3; HT_HG-U133A	TNFRSF25 MAPT LRRK1 RUNX1 PRDM2 PRUNE1 ELK4 SRRM2 SOS2	7.52e-06	199	151	9	5789_DN
Drug	Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A	PRR36 BHLHE40 GGA3 SMG7 SIPA1L1 NAV2 PARD3 SMG6	3.50e-05	186	151	8	6793_UP
Drug	5707885; Down 200; 50uM; PC3; HT_HG-U133A	SPHK2 PRR36 LRRK1 RUNX1 BCL9 HIVEP3 NFATC3 ELK4	4.23e-05	191	151	8	6390_DN
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A	PTBP3 INCENP PRDM2 PRUNE1 PER3 NFATC3 PARD3 SOS2	4.39e-05	192	151	8	4311_DN
Drug	Ricinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A	RUNX1 PRDM2 SMG7 NFATC3 SIPA1L1 KIF3C PARD3 SOS2	4.55e-05	193	151	8	2505_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	SOX3 PTBP3 GIT2 BCL9 CNNM4 MEGF9 ELK4 SOS2	4.72e-05	194	151	8	7481_DN
Drug	Leucomisine [17946-87-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	USP36 PTBP3 MAPT GRB7 SMG7 SNAPC4 AGRN SOS2	4.72e-05	194	151	8	6767_DN
Drug	Sulfameter [651-06-9]; Down 200; 14.2uM; PC3; HT_HG-U133A	VGF PTBP3 TNFRSF25 GIT2 CNNM4 RGS14 SMG7 SNAPC4	4.72e-05	194	151	8	5732_DN
Drug	Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A	PTBP3 MAPT PRUNE1 SMG7 TMEM259 SIPA1L1 MSL3 SOS2	4.72e-05	194	151	8	3454_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A	TNFRSF25 MAPT RUNX1 RGS14 TMEM259 MSL3 AGRN CNOT3	4.72e-05	194	151	8	4242_DN
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; PC3; HT_HG-U133A	PTBP3 LRRK1 BHLHE40 NFATC3 TMEM259 ELK4 AGRN SOS2	4.90e-05	195	151	8	6762_DN
Drug	PF-00539745-00 [351321-33-0]; Down 200; 10uM; PC3; HT_HG-U133A	INCENP ETV6 RUNX1 NFATC3 TMEM259 AUTS2 SNAPC4 SOS2	4.90e-05	195	151	8	5979_DN
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A	GRB7 HIVEP3 SIPA1L1 MSL3 KIF3C ELK4 CNOT3 SOS2	4.90e-05	195	151	8	5240_UP
Drug	Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; PC3; HT_HG-U133A	PTBP3 TNFRSF25 GRB7 TUT1 RUNX1 PER3 SNAPC4 SOS2	4.90e-05	195	151	8	5763_DN
Drug	Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SOX3 ATG2B GRB7 GIT2 RUNX1 MEGF9 MSL3 SRRM2	4.90e-05	195	151	8	2649_DN
Drug	Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; PC3; HT_HG-U133A	PTBP3 ETV6 RUNX1 RGS14 NFATC3 TMEM259 ELK4 SOS2	5.08e-05	196	151	8	4000_UP
Drug	(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A	VGF PTBP3 TNFRSF25 LRRK1 HIVEP3 MEGF9 MSL3 ELK4	5.08e-05	196	151	8	3789_DN
Drug	Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A	INCENP GIT2 RUNX1 PRUNE1 NFATC3 RIMS2 SKAP2 SOS2	5.08e-05	196	151	8	4699_UP
Drug	Miconazole [22916-47-8]; Down 200; 9.6uM; PC3; HT_HG-U133A	MAPT CHAF1A TACC2 SRGAP2 LRRK1 PRUNE1 SNAPC4 SMG6	5.08e-05	196	151	8	6615_DN
Drug	Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A	TNFRSF25 MAPT GIT2 BCL9 RGS14 ELK4 PARD3 CNOT3	5.08e-05	196	151	8	5079_DN
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	PTBP3 MAPT GIT2 SMG7 PER3 NFATC3 AGAP2 ZNF574	5.08e-05	196	151	8	4347_DN
Drug	Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	TNFRSF25 MAPT RUNX1 GGA3 CNNM4 RGS14 NFATC3 ZFHX2	5.08e-05	196	151	8	5757_DN
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A	TNFRSF25 PRR36 CAMTA2 RUNX1 GGA3 SMG7 PARD3 SRRM2	5.08e-05	196	151	8	5232_UP
Drug	AH6809; Down 200; 1uM; PC3; HT_HG-U133A	TNFRSF25 PCLO GRB7 GIT2 PTBP1 BHLHE40 ELK4 SNAPC4	5.08e-05	196	151	8	7049_DN
Drug	Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A	USP36 CHAF1A GIT2 CLOCK GGA3 CNNM4 NFATC3 SRRM2	5.08e-05	196	151	8	7485_DN
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; PC3; HT_HG-U133A	TNFRSF25 SPHK2 MAPT TUT1 RUNX1 HIVEP3 SMG7 MEGF9	5.08e-05	196	151	8	3743_DN
Drug	Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	PTBP3 SPHK2 CHAF1A PRUNE1 MEGF9 NFATC3 ELK4 CAMSAP2	5.08e-05	196	151	8	4840_DN
Drug	5194442; Down 200; 20uM; PC3; HT_HG-U133A	MAPT TUT1 RUNX1 CNNM4 TENM4 SMG7 MSL3 SKAP2	5.26e-05	197	151	8	6594_DN
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	GIT2 RUNX1 RGS14 ELK4 SNAPC4 SRRM2 SMG6 SOS2	5.26e-05	197	151	8	3763_DN
Drug	Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A	SOX3 TNFRSF25 GRB7 AHDC1 HIVEP3 KIF3C SRRM2 SMG6	5.26e-05	197	151	8	3195_DN
Drug	Prednisone [53-03-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	VGF INCENP MAPT RUNX1 HIVEP3 SNAPC4 ZNF574 SOS2	5.26e-05	197	151	8	4577_DN
Drug	Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; MCF7; HT_HG-U133A	MAPT GIT2 RUNX1 MEGF9 MSL3 SRRM2 AGAP2 ZNF574	5.26e-05	197	151	8	2635_DN
Drug	Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; PC3; HT_HG-U133A	MAPT CHAF1A GIT2 RUNX1 HIVEP3 CNNM4 ELK4 SMG6	5.26e-05	197	151	8	6360_DN
Drug	Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; PC3; HT_HG-U133A	PCDHGB6 LRRK1 RUNX1 PRUNE1 PER3 AUTS2 RIMS2 CNOT3	5.26e-05	197	151	8	4570_UP
Drug	Amodiaquin dihydrochloride dihydrate [6398-98-7]; Down 200; 8.6uM; PC3; HT_HG-U133A	VGF GIT2 PRUNE1 CNNM4 SMG7 ZFHX2 KIF3C CNOT3	5.26e-05	197	151	8	5747_DN
Drug	Trioxsalen [3902-71-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A	SPHK2 RUNX1 PRDM2 HIVEP3 TMEM259 MSL3 MNDA SOS2	5.46e-05	198	151	8	6216_UP
Drug	Tiabendazole [148-79-8]; Up 200; 19.8uM; HL60; HT_HG-U133A	VGF AMPH MAPT GRB7 LRRK1 CNNM4 NFATC3 RIMS2	5.46e-05	198	151	8	2479_UP
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; PC3; HT_HG-U133A	TNFRSF25 TUT1 RUNX1 HIVEP3 MEGF9 SIPA1L1 KIF3C SOS2	5.46e-05	198	151	8	5799_DN
Drug	Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	INCENP NR1H3 TUT1 GIT2 BCL9 AHDC1 SIPA1L1 PARD3	5.46e-05	198	151	8	5524_DN
Drug	Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; PC3; HT_HG-U133A	VGF STARD13 PTBP3 GRB7 RUNX1 RGS14 ZFHX2 ZNF574	5.46e-05	198	151	8	5731_DN
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	VGF TNFRSF25 SPHK2 PRR36 CHAF1A HIVEP3 AGAP2 SOS2	5.46e-05	198	151	8	4351_DN
Drug	Bufexamac [2438-72-4]; Up 200; 18uM; PC3; HT_HG-U133A	TNFRSF25 MAPT GRB7 PRDM2 MSL3 PRDM12 ELK4 AGAP2	5.65e-05	199	151	8	5090_UP
Drug	Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; PC3; HT_HG-U133A	VGF TUT1 GIT2 RUNX1 PRDM2 ELK4 SNAPC4 SOS2	5.65e-05	199	151	8	5820_UP
Drug	Iodipamide [606-17-7]; Down 200; 3.6uM; MCF7; HT_HG-U133A	PCLO GIT2 RUNX1 AHDC1 MICALL1 SIPA1L1 SKAP2 AGRN	5.86e-05	200	151	8	5510_DN
Drug	Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; HL60; HT_HG-U133A	TNFRSF25 PSD ZNF362 GGA3 CNNM4 PER3 MAP4K1 AGAP2	5.86e-05	200	151	8	6128_UP
Drug	Nifedipine [21829-25-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	USP36 PTBP3 RUNX1 PRDM2 NFATC3 NAV2 ZFHX2 KIF3C	5.86e-05	200	151	8	1692_UP
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	MARK3 TACC2 RUNX1 PRDM2 PRUNE1 MRTFB NAV2	2.04e-04	180	151	7	4541_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A	TNFRSF25 AMPH PRR36 GRB7 RUNX1 BHLHE40 RGS14	2.25e-04	183	151	7	4732_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	VGF STARD13 SPHK2 ATG2B GRB7 GIT2 ELK4	2.49e-04	186	151	7	1664_UP
Drug	Bisacodyl [603-50-9]; Up 200; 11uM; PC3; HT_HG-U133A	VGF AMPH RUNX1 ELK4 RIMS2 AGAP2 SOS2	2.57e-04	187	151	7	4616_UP
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A	STARD13 PTBP3 TMEM259 MSL3 KIF3C ELK4 SNAPC4	2.66e-04	188	151	7	5565_DN
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	TNFRSF25 PCLO GRB7 TUT1 ZNF362 RUNX1 CNOT3	2.74e-04	189	151	7	5587_UP
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	TNFRSF25 INCENP MAPT GRB7 TMEM259 SNAPC4 SOS2	2.83e-04	190	151	7	4442_DN
Drug	Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A	VGF SPHK2 PRR36 MAPT ETV6 NFATC3 SOS2	2.83e-04	190	151	7	3373_DN
Drug	Azacytidine-5 [320-67-2]; Down 200; 16.4uM; PC3; HT_HG-U133A	GIT2 RUNX1 BHLHE40 AHDC1 PRUNE1 MEGF9 NFATC3	2.83e-04	190	151	7	4010_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	CHAF1A GIT2 CNNM4 CSNK1D SIPA1L1 SNAPC4 AGRN	2.92e-04	191	151	7	1057_DN
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; PC3; HT_HG-U133A	GRB7 TUT1 LRRK1 RUNX1 RGS14 MAP4K1 MSL3	2.92e-04	191	151	7	1243_UP
Drug	Prednisolone [50-24-8]; Up 200; 11uM; HL60; HT_HG-U133A	SPHK2 ZNF362 MICALL1 CNNM4 PARD3 RIMS2 SOS2	2.92e-04	191	151	7	2393_UP
Drug	Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A	MAPT GRB7 PTBP1 BHLHE40 PER3 SNAPC4 SOS2	3.02e-04	192	151	7	4496_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A	SPHK2 PTBP1 AHDC1 TMEM259 SNAPC4 AGRN CNOT3	3.02e-04	192	151	7	4330_DN
Drug	Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A	VGF USP36 GIT2 PRDM2 MICALL1 CAMSAP2 SOS2	3.02e-04	192	151	7	4104_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	VGF SOX3 USP36 PRDM2 SMG7 RIMS2 SRRM2	3.11e-04	193	151	7	1647_UP
Drug	Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A	TNFRSF25 PRR36 BHLHE40 PER3 ELK4 PARD3 RIMS2	3.11e-04	193	151	7	4161_DN
Drug	Cefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A	VGF SPHK2 MAPT RUNX1 AGRN CNOT3 SOS2	3.11e-04	193	151	7	4245_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	VGF TNFRSF25 SPHK2 SLC4A2 RGS14 TBC1D10B AGRN	3.11e-04	193	151	7	3262_UP
Drug	Parbendazole [14255-87-9]; Down 200; 16.2uM; PC3; HT_HG-U133A	VGF TNFRSF25 MAPT GRB7 RUNX1 TENM4 SOS2	3.11e-04	193	151	7	3799_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	GIT2 GGA3 MICALL1 TMEM259 KIF3C SRRM2 CNOT3	3.11e-04	193	151	7	6981_DN
Drug	PHA-00851261E [724719-49-7]; Up 200; 1uM; MCF7; HT_HG-U133A	TNFRSF25 CHAF1A PTBP1 HIVEP3 SMG7 AGAP2 SMG6	3.11e-04	193	151	7	3857_UP
Drug	Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A	PTBP3 INCENP GIT2 RUNX1 BHLHE40 NFATC3 SOS2	3.11e-04	193	151	7	4725_UP
Drug	Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	INCENP GIT2 RUNX1 BHLHE40 NAV2 KIF3C ELK4	3.11e-04	193	151	7	5315_UP
Drug	Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	SOX3 RUNX1 BHLHE40 PRDM2 MSL3 KIF3C AGRN	3.21e-04	194	151	7	2828_UP
Drug	Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A	CLOCK PRDM2 GGA3 SMG7 ZFHX2 SNAPC4 SRRM2	3.21e-04	194	151	7	5362_UP
Drug	Trazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A	TNFRSF25 SPHK2 RUNX1 SMG7 ZFHX2 PARD3 SOS2	3.21e-04	194	151	7	7410_UP
Drug	Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; PC3; HT_HG-U133A	RUNX1 PPP1R1A HAVCR1 PRDM12 RIMS2 AGAP2 SMG6	3.21e-04	194	151	7	6710_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	PTBP3 PCLO PRUNE1 NFATC3 TMEM259 ELK4 SOS2	3.21e-04	194	151	7	4736_DN
Drug	Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A	PTBP3 TNFRSF25 RUNX1 SMG7 MSL3 ZFHX2 ELK4	3.21e-04	194	151	7	4281_DN
Drug	paclitaxel; Down 200; 0.1uM; MCF7; HG-U133A	SOX3 ATG2B GIT2 RUNX1 BCL9 CNNM4 PARD3	3.21e-04	194	151	7	640_DN
Drug	Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A	PTBP3 NR1H3 RUNX1 MICALL1 PRUNE1 SRRM2 CAMSAP2	3.21e-04	194	151	7	6201_DN
Drug	Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; HL60; HT_HG-U133A	PTBP3 RUNX1 MICALL1 HOXA5 MRTFB MAP4K1 SOS2	3.21e-04	194	151	7	2391_UP
Drug	Cyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A	SOX3 GRB7 CAMTA2 LRCH3 PER3 MSL3 AGRN	3.21e-04	194	151	7	2880_DN
Drug	Androsterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A	USP36 PTBP3 GIT2 BCL9 NFATC3 KIF3C SOS2	3.21e-04	194	151	7	5696_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A	TNFRSF25 SPHK2 AMPH RUNX1 KCNB2 HIVEP3 PRDM12	3.21e-04	194	151	7	3838_UP
Drug	Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A	MAPT PTBP2 RUNX1 TENM4 MSL3 KIF3C RIMS2	3.21e-04	194	151	7	2789_UP
Disease	cortical thickness	SOX5 MAPT PTBP2 MARK3 CHAF1A GLIS3 TACC2 SRGAP2 CLOCK MICALL1 ARID1B KANSL1 SMG7 MEGF9 NAV2 AUTS2 FOXP1 TMEM131 SSH2 PARD3 PLEKHA7 SMG6 SOS2	7.49e-09	1113	147	23	EFO_0004840
Disease	reaction time measurement	SOX5 STIM2 MAPT PTBP2 PARD3B TACC2 SRGAP2 POM121 KANSL1 SMG7 CSNK1D NAV2 AUTS2 FOXP1 PRRC1 RAI1	2.04e-07	658	147	16	EFO_0008393
Disease	Precursor B-cell lymphoblastic leukemia	ETV6 RUNX1 AUTS2 FOXP1	3.31e-06	21	147	4	C1292769
Disease	Neurodevelopmental Disorders	PARD3B CHD2 HIVEP3 KMT2C ARID1B FOXP1	7.36e-06	93	147	6	C1535926
Disease	hematocrit	STARD13 SOX5 MAPT CHAF1A GLIS3 ETV6 PTBP1 RUNX1 RBBP8NL SLC4A2 RGS14 ARID1B FOXP1 ASXL2 SSH2 SLC14A2 RAI1	1.24e-05	1011	147	17	EFO_0004348
Disease	endometrial cancer (is_marker_for)	RUNX1 GHRH TNFRSF1B SMAD2	2.75e-05	35	147	4	DOID:1380 (is_marker_for)
Disease	Burkitt Lymphoma	ETV6 RUNX1 AUTS2 FOXP1	3.08e-05	36	147	4	C0006413
Disease	balding measurement	MAPT GLIS3 LRRK1 RUNX1 CLOCK BHLHE40 ZC3H11A AUTS2 FOXP1 ASXL2 PARD3 SKAP2 SLC14A2 SMG6	4.45e-05	792	147	14	EFO_0007825
Disease	multiple sclerosis	TNFRSF25 TENT4A GRB7 ETV6 FAM221B RGS14 KANSL1 FAM167A-AS1 FOXP1 SKAP2 AGAP2 SMG6	4.52e-05	594	147	12	MONDO_0005301
Disease	intraocular pressure measurement	PCLO GLIS3 PARD3B NR1H3 CAMTA2 HIVEP3 CPXM1 FOXP1 PLEKHA7 SMG6 SOS2	5.19e-05	509	147	11	EFO_0004695
Disease	pulse pressure measurement	USP36 RBM33 MARK3 CHD2 ZBTB41 AHDC1 PIK3R4 HIVEP3 FNDC1 ARID1B TENM4 KANSL1 KIAA1217 CPXM1 FOXP1 PLEKHA7 SLC14A2 SMG6 SOS2	6.58e-05	1392	147	19	EFO_0005763
Disease	Autism Spectrum Disorders	SOX5 CHD2 SHANK3 FOXP1 RAI1	6.82e-05	85	147	5	C1510586
Disease	Platelet Disorder, Familial, with Associated Myeloid Malignancy	ETV6 RUNX1	7.37e-05	3	147	2	C1832388
Disease	Advanced Sleep-Phase Syndrome, Familial	PER3 CSNK1D	7.37e-05	3	147	2	C1858496
Disease	Psychomotor Agitation	MAPT RAI1	1.47e-04	4	147	2	C3887612
Disease	Akathisia	MAPT RAI1	1.47e-04	4	147	2	C0392156
Disease	chronic obstructive pulmonary disease	GLIS3 TUT1 SRGAP2 ZNF362 BCL9 TENM4 KANSL1 FAM167A-AS1 FOXP1 SSH2 SLC14A2 SMG6	1.80e-04	688	147	12	EFO_0000341
Disease	Dupuytren Contracture	GLIS3 TACC2 SRGAP2 LRRK1 BOP1	2.12e-04	108	147	5	EFO_0004229
Disease	migraine disorder, type 1 diabetes mellitus	FOXI3 SLC45A1	2.44e-04	5	147	2	MONDO_0005147, MONDO_0005277
Disease	coronary artery disease	PCNX3 TENT4A MARK3 CHD2 KCNB2 CLOCK AHDC1 KIAA0319 FNDC1 ZC3H11A KIAA1217 PLEKHA7 SLC14A2 SMAD2 RAI1 SMG6	3.15e-04	1194	147	16	EFO_0001645
Disease	Malignant neoplasm of breast	PCDHGB6 AVPR2 GRB7 TACC2 GGA3 MICALL1 PIK3R4 CNNM4 ARID1B ZC3H11A CLCN1 PER3 CSNK1D SIPA1L1 AGAP2	3.17e-04	1074	147	15	C0006142
Disease	Acute Myeloid Leukemia, M1	ETV6 RUNX1 KMT2C ASXL2 AGRN	4.16e-04	125	147	5	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	ETV6 RUNX1 KMT2C ASXL2 AGRN	4.16e-04	125	147	5	C1879321
Disease	alcohol use disorder (implicated_via_orthology)	PSD ARID1B MAP4K1 AUTS2 SSH2 SRRM2	4.51e-04	195	147	6	DOID:1574 (implicated_via_orthology)
Disease	alcohol consumption measurement	SOX5 MAPT MARK3 PCLO MICALL1 KANSL1 MEGF9 AUTS2 FOXP1 AKAP11 ASXL2 PARD3 RIMS2 SLC14A2 AGRN ZNF574	4.85e-04	1242	147	16	EFO_0007878
Disease	age at diagnosis, osteoarthritis	MAPT KANSL1	5.09e-04	7	147	2	EFO_0004918, MONDO_0005178
Disease	Angle Closure Glaucoma	GLIS3 PLEKHA7	5.09e-04	7	147	2	C0017605
Disease	neuroticism measurement, cognitive function measurement	SOX5 PCLO GLIS3 LHX8 KIAA1217 SIPA1L1 NAV2 AUTS2 FOXP1 RAI1	5.67e-04	566	147	10	EFO_0007660, EFO_0008354
Disease	Abnormality of refraction	MAPT PCLO GLIS3 PTBP1 RUNX1 PIK3R4 HIVEP3 AUTS2 FOXP1 PARD3 SLC14A2	5.76e-04	673	147	11	HP_0000539
Disease	testosterone measurement	STARD13 SOX5 SPEM3 MAPT GPR182 GLIS3 NIBAN2 GGA3 SHROOM4 RGS14 ARID1B PER3 AUTS2 FOXP1 RAI1 SOS2	6.43e-04	1275	147	16	EFO_0004908
Disease	kidney disease (is_marker_for)	HAVCR1 ARID1B	6.77e-04	8	147	2	DOID:557 (is_marker_for)
Disease	tumor necrosis factor receptor II measurement	RGS14 TNFRSF1B	6.77e-04	8	147	2	EFO_0008384
Disease	chronic central serous retinopathy	RBBP8NL MEGF9	8.67e-04	9	147	2	EFO_0009363
Disease	neuroimaging measurement	SOX5 MAPT MARK3 CHAF1A GLIS3 TACC2 KANSL1 NAV2 FOXP1 SSH2 PARD3 PLEKHA7 RAI1 SMG6	9.43e-04	1069	147	14	EFO_0004346
Disease	neutrophil percentage of leukocytes	SPHK2 MAPT MARK3 CLOCK KANSL1 FOXP1 AKAP11 TMEM131 SNAPC4 SKAP2	1.00e-03	610	147	10	EFO_0007990
Disease	biological sex	SOX5 AUTS2 FOXP1 PARD3 RIMS2 SLC14A2	1.07e-03	230	147	6	PATO_0000047
Disease	neuroblastoma (is_implicated_in)	CHAF1A ARID1B	1.08e-03	10	147	2	DOID:769 (is_implicated_in)
Disease	cortical surface area measurement	SOX5 PCNX3 MAPT CHAF1A GLIS3 PARD3B ARID1B KANSL1 NAV2 AUTS2 FOXP1 SSH2 PARD3 PLEKHA7 SMG6 SOS2	1.13e-03	1345	147	16	EFO_0010736
Disease	osteoarthritis, knee	SOX5 GLIS3 PARD3B KIAA1217 SMG6	1.20e-03	158	147	5	EFO_0004616
Disease	eosinophil count	TENT4A MAPT ZNF362 DCST2 PTBP1 RUNX1 ZAP70 HIVEP3 RGS14 FNDC1 KANSL1 FOXP1 TMEM131 TNFRSF1B SKAP2 SMAD2 RAI1	1.22e-03	1488	147	17	EFO_0004842
Disease	primary angle closure glaucoma	GLIS3 PLEKHA7	1.32e-03	11	147	2	EFO_1001506
Disease	ovarian carcinoma, COVID-19	MAPT KANSL1	1.32e-03	11	147	2	EFO_0001075, MONDO_0100096
Disease	vital capacity	MAPT DSCR4 PCLO GLIS3 HOXA5 KANSL1 AUTS2 FOXP1 BOP1 SNAPC4 PARD3 SKAP2 SLC14A2 SMG6 SOS2	1.33e-03	1236	147	15	EFO_0004312
Disease	physical activity measurement	SOX5 KANSL1 SIPA1L1 AUTS2 FOXP1 RIMS2	1.47e-03	245	147	6	EFO_0008002
Disease	red blood cell density measurement	STARD13 MAPT ETV6 RUNX1 RBBP8NL RGS14 ARID1B KANSL1 FOXP1 SSH2 SLC14A2 SMG6	1.56e-03	880	147	12	EFO_0007978
Disease	rheumatoid arthritis (implicated_via_orthology)	ZAP70 KMT2C	1.57e-03	12	147	2	DOID:7148 (implicated_via_orthology)
Disease	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	ETV6 RUNX1	1.57e-03	12	147	2	C0023485
Disease	Schizophrenia	SOX5 CACNA1B PSD BCL9 CLOCK BHLHE40 SHANK3 TENM4 AUTS2 TNFRSF1B RIMS2 RAI1	1.61e-03	883	147	12	C0036341
Disease	neurotic disorder	MAPT PCLO GLIS3 SIPA1L1	1.66e-03	101	147	4	EFO_0004257
Disease	Leukemia, Myelocytic, Acute	ETV6 RUNX1 KMT2C ASXL2 AGRN	1.79e-03	173	147	5	C0023467
Disease	brain measurement, neuroimaging measurement	SOX5 MARK3 GLIS3 KANSL1 NAV2 FOXP1 SSH2 PARD3 SMG6	1.81e-03	550	147	9	EFO_0004346, EFO_0004464
Disease	breast carcinoma	INCENP MAPT TACC2 HIVEP3 ARID1B ZC3H11A KANSL1 MAST1 FOXP1 ASXL2 SLC45A1 SLC14A2 SMG6	1.81e-03	1019	147	13	EFO_0000305
Disease	Intellectual Disability	CACNA1B FHIP2A SHANK3 SHROOM4 KMT2C KANSL1 MSL3 RAI1	1.86e-03	447	147	8	C3714756
Disease	forced expiratory volume	GLIS3 ETV6 PARD3B BCL9 HOXA5 SSC5D KANSL1 FOXP1 BOP1 SKAP2 SLC14A2	2.06e-03	789	147	11	EFO_0004314
Disease	mean reticulocyte volume	SPHK2 MAPT MARK3 CHAF1A ETV6 RUNX1 HAVCR1 KANSL1 KIAA1217 MAST1 FOXP1	2.27e-03	799	147	11	EFO_0010701
Disease	monoclonal gammopathy	AUTS2 RIMS2 SLC14A2	2.36e-03	53	147	3	EFO_0000203
Disease	Anilide use measurement	MAPT KANSL1	2.48e-03	15	147	2	EFO_0009938
Disease	myeloid white cell count	SPHK2 GLIS3 LRRK1 BCL9 HIVEP3 HAVCR1 XPO6 FOXP1 AKAP11 KIF3C SSH2 SMG6	2.62e-03	937	147	12	EFO_0007988
Disease	Bipolar Disorder	VGF CACNA1B PCLO BCL9 CLOCK BHLHE40 TENM4 PER3	2.78e-03	477	147	8	C0005586
Disease	colorectal mucinous adenocarcinoma	SOX5 ETV6	2.83e-03	16	147	2	EFO_0009361
Disease	Seasonal Affective Disorder	CLOCK PER3	2.83e-03	16	147	2	C0085159
Disease	Alzheimer's disease (implicated_via_orthology)	SOX5 MAPT HIVEP3	2.91e-03	57	147	3	DOID:10652 (implicated_via_orthology)
Disease	omega-3 polyunsaturated fatty acid measurement	INCENP MAPT HAVCR1 KANSL1	2.92e-03	118	147	4	EFO_0010119
Disease	Muscle hypotonia	KANSL1 MSL3	3.19e-03	17	147	2	C0026827
Disease	plasma beta-amyloid 1-40 measurement	STARD13 EP400P1	3.19e-03	17	147	2	EFO_0005659
Disease	Acute myeloid leukemia	ETV6 RUNX1	3.19e-03	17	147	2	cv:C0023467
Disease	acute kidney failure (is_marker_for)	HAVCR1 TNFRSF1B	3.19e-03	17	147	2	DOID:3021 (is_marker_for)
Disease	LEUKEMIA, ACUTE MYELOID	ETV6 RUNX1	3.19e-03	17	147	2	601626
Disease	FEV/FEC ratio	STARD13 SOX5 GLIS3 ETV6 TUT1 SRGAP2 HIVEP3 NAV2 FOXP1 SSH2 PARD3 SKAP2 SLC14A2 SMG6	3.38e-03	1228	147	14	EFO_0004713
Disease	taste liking measurement	MAPT GLIS3 ARID1B KANSL1 AUTS2 FAM167A-AS1 FOXP1	3.40e-03	388	147	7	EFO_0010155
Disease	mean arterial pressure	USP36 STIM2 PCNX3 HIVEP3 KIAA1217 AUTS2 PLEKHA7 SMG6	3.64e-03	499	147	8	EFO_0006340
Disease	t-tau measurement	MAPT GLIS3 ETV6 PARD3	3.70e-03	126	147	4	EFO_0004760
Disease	brain connectivity measurement	MAPT TENM4 KANSL1 NAV2 FOXP1 SSH2 SMG6	4.02e-03	400	147	7	EFO_0005210
Disease	Tinnitus	PCNX3 ZAP70 SIPA1L1 TMEM131	4.13e-03	130	147	4	HP_0000360
Disease	IgA glomerulonephritis (is_marker_for)	HAVCR1 TNFRSF1B	4.42e-03	20	147	2	DOID:2986 (is_marker_for)
Disease	androgenetic alopecia	MAPT RUNX1 KANSL1 SLC14A2	4.48e-03	133	147	4	EFO_0004191
Disease	esophagus adenocarcinoma (is_implicated_in)	GRB7 FOXP1	4.86e-03	21	147	2	DOID:4914 (is_implicated_in)
Disease	alkaline phosphatase measurement	MAPT RUNX1 FHIP2A ATXN1L BHLHE40 KIAA0319 HIVEP3 POM121 KANSL1 NFATC3 XPO6 RAI1	4.95e-03	1015	147	12	EFO_0004533

Protein segments in the cluster

Peptide	Gene	Start	Entry
EPEPPLLCTSPLSHS	BOP1	31	Q14137
NPPPTSLDLPSHVAV	SMG6	1041	Q86US8
AERTSPSSPAPLPHQ	SLC4A2	166	P04920
STTSPKLNLPPSPHA	AGAP11	231	Q8TF27
LPSPLPAHPSVDSSV	BHLHE40	381	O14503
LAPSSTAHSQTTPPP	AGRN	1006	O00468
NVDHFPSSTPPSELP	CAMTA2	991	O94983
TPALHSSPAQPPAET	CPXM1	41	Q96SM3
TASPPSALSHPSPLE	LINC00528	76	Q8N1L1
EFAPATPPSTPHNSS	AKAP11	1131	Q9UKA4
SPSSLQPPPDQTSKH	AGAP2	781	Q99490
TAEPHVAPSPTLPST	GIT2	626	Q14161
VPIEPDSPPSLSTHF	AASDH	86	Q4L235
QTPPSLPNHISRAPS	ARID1B	1611	Q8NFD5
AASPALHSTSPLPDP	DSCR4	21	P56555
LHSTSPLPDPASASP	DSCR4	26	P56555
SAPHLASPPATPKAD	AHDC1	1501	Q5TGY3
APPKQHSSTSPFPTS	CHAF1A	301	Q13111
STTPDRPPPSQASSH	CACNA1B	2036	Q00975
SHSLSSLPPLGDPPN	ATG2B	416	Q96BY7
STVLPLPADSPTHQP	ASXL2	1291	Q76L83
PSPTASPNHTLAPAS	AMPH	271	P49418
ILSSTSAPPASAQPP	CNOT3	571	O75175
PLSEPPSSTPQSTHA	RAI1	496	Q7Z5J4
AADPSVPPNPLTHLS	RBPJL	6	Q9UBG7
LLNSSHPVPTQSPLP	RBM33	491	Q96EV2
AAPEASSPPASPLQH	NIBAN2	686	Q96TA1
DLTSHPETLTSQAPP	PCDHGB6	796	Q9Y5F9
QAHATSLPPRASSPP	NR1H3	186	Q13133
SPPLKLTPASSTHPN	PRUNE1	321	Q86TP1
PASSESHPKPSSPRQ	ETV6	246	P41212
AESEVPPSPTPHSAL	PARD3B	651	Q8TEW8
ESPSTLLRPSHSPEP	FOXI3	276	A8MTJ6
HASPLPPSAAPTTDS	LRCH3	626	Q96II8
PTLPASPSNHVSSLP	KMT2C	2941	Q8NEZ4
SPSNHVSSLPPFIAP	KMT2C	2946	Q8NEZ4
QSVRHSPIAPSSPSP	INCENP	301	Q9NQS7
PLDTEPPAASHTANP	LRRK1	1791	Q38SD2
LPPTQEALPSSHSSP	IL18BP	176	O95998
PSPLLSPSANLATSH	ATXN1L	156	P0C7T5
SPQRPPPSTTHASLA	KIF3C	766	O14782
SPTSPLSPHSNKSSP	PCLO	2556	Q9Y6V0
SPPRENPSHPTASAL	PER3	976	P56645
LTSLSNNPPVAHPTP	PCNX3	1846	Q9H6A9
PHTSESPLVPSPSQI	FAM221B	51	A6H8Z2
TSTHSPQPDPLPCSA	HOXA5	91	P20719
APPTPLTPTSHTANT	CSNK1D	341	P48730
SEASPQSLPHTPTTP	FOXP1	396	Q9H334
ENVHSPLPISPSPSE	MRTFB	486	Q9ULH7
PLPISPSPSEQSSLS	MRTFB	491	Q9ULH7
SPPLLNPSTPQSTES	MSL3	311	Q8N5Y2
RASEPPPPNSSSSVH	AUTS2	1001	Q8WXX7
PPPEHTTDLFLPLSS	KANSL1	486	Q7Z3B3
DLPSSSNSSVLPTPP	MEGF9	176	Q9H1U4
SQPSLPLTLPSPSHQ	EP400P1	31	Q6ZTU2
PLASPSHITTANLPP	EP400P1	241	Q6ZTU2
HKPTSTLSFISPPQP	KLKP1	16	Q107X0
PQSPSSISSLPSHAP	LHX4	311	Q969G2
PNHSSSTPVTAVPPS	LHX8	286	Q68G74
SHSEPPSATPSPALS	MICALL1	496	Q8N3F8
NSLSSVLAPAPTPPS	GGA3	336	Q9NZ52
PSTALQAHSPALPAP	PRDM12	326	Q9H4Q4
SPPHLSSSPEDLCPA	GRB7	6	Q14451
NIPLSPLAHTPSPTQ	MAST1	1201	Q9Y2H9
AIPSASPNPLSSPHL	TENT4A	691	Q5XG87
QTHDVSSLPLPHPSP	RIMS2	931	Q9UQ26
APASPPTSLLAPSTN	POM121	581	Q96HA1
QSPHSSPLAPAAAPS	RBBP8NL	301	Q8NC74
TERSPLPPPSASHLQ	KCNB2	616	Q92953
RTPSPPLSSHPDIDT	ELK4	266	P28324
HPAVSDPRSPPSQKS	CHD2	1781	O14647
EPSSPSPRAPASSQH	FNDC1	476	Q4ZHG4
SPRAPASSQHPSVPA	FNDC1	481	Q4ZHG4
ASPVHLKSPSLPAPS	BCL9	916	O00512
SPHNPSSQLPPLTAV	GLIS3	591	Q8NEA6
PASPSLSHEATPLSQ	MARK3	581	P27448
LPHAPQDSVPPSDSA	TMEM259	576	Q4ZIN3
KPRASSPLSNNHPPT	CSAG2	71	Q9Y5P2
PDPSTLASPHPSTEA	FAM167A-AS1	21	Q96KT0
EHLLASAAPSPAPPT	FOXS1	266	O43638
AQAHPPKEPPASSSS	KANK4	616	Q5T7N3
TSPEPHRPPETSSAT	DCST2	731	Q5T1A1
LSSSPPATPDHPKND	FHIP2A	546	Q5W0V3
PSHTATNFSSPISPP	SLC45A1	361	Q9Y2W3
SDSPRPTHPSPQSSN	CAMSAP2	961	Q08AD1
EAPSSLSTPHPEEPT	DHRS13	331	Q6UX07
RTSSPPSSPQHSPAL	PRDM2	736	Q13029
SASPHPCPSPLSNAT	PRDM2	1001	Q13029
LPVLPPHLSDQSSSS	PARD3	766	Q8TEW0
DHPPLPQTSSSTPSN	MNDA	171	P41218
PPPSTSSPHLTAHSE	MAP4K1	441	Q92918
PAPTPNPRASLNHST	RUNX1	216	Q01196
HLEPSGNPLPATPTT	STK11IP	436	Q8N1F8
SLHSPADPSHLSPPA	RGL2	591	O15211
SEPSSPPPAIASHSQ	SOX3	376	P41225
PRPAPASPHISSQTA	STARD13	596	Q9Y3M8
QLRDHLPPPSSASPS	UVSSA	466	Q2YD98
PNTPSTPPVSASSDL	SOS2	1086	Q07890
SPPSPQPTKVSRHAS	SRRM2	421	Q9UQ35
SQTHSLPAPESPEPA	VGF	121	O15240
HSSPSLQPKPSSQPR	PSD	991	A5PKW4
FPPSATLHLSNIPPS	PTBP2	451	Q9UKA9
SPDPLLSSFSHPDSP	TBC1D25	546	Q3MII6
DHPLPISNPLTSSQP	SKAP2	241	O75563
SPSLQAPPSPLALSS	PRR36	596	Q9H6K5
SLPASPPLQTSLSPA	PRR36	661	Q9H6K5
SLAPPSLQTPPASLT	PRR36	716	Q9H6K5
PPLQTASAPLTTPHL	PRR36	766	Q9H6K5
HHLLPNTSPISPTQP	GPR182	386	O15218
ATSPSSPQPAETHPT	HAVCR1	226	Q96D42
SSNPSSLPSSPPTHN	SMG7	1006	Q92540
PPPSSHEKEPLASSA	NAV2	326	Q8IVL1
LFPHPPVPSLSTSES	PLEKHA7	846	Q6IQ23
HALSSPQSPFPSTPT	SIPA1L1	1561	O43166
SPKLSHSPQPPSLGD	KIAA1217	121	Q5T5P2
PPESPPLTASNTSLL	SHROOM4	626	Q9ULL8
KAPSPQHTFPSTSIP	SLC26A10	26	Q8NG04
PVSHFPPSTSAPNTL	PRRC1	106	Q96M27
PAPHTSTSQIPTLEP	SSC5D	1371	A1L4H1
TPPPTHTPHSASDLT	SSC5D	1421	A1L4H1
LTLSNSSHCSPPPPL	GHRH	11	P01286
IPQPSAAPHLSTFDP	B3GNT9	341	Q6UX72
PSLSPRSHVPSPHQA	ACD	346	Q96AP0
PTDTSTPPRQHLPAH	CLOCK	456	O15516
LHPSTTAPLSPEEPN	CLCN1	731	P35523
SVPSDRSPAHPTPLS	CNNM4	646	Q6P4Q7
ASSAPPLSELQPSPH	PIK3R4	1226	Q99570
AAPTLPAHPSTLTHP	ZAP70	266	P43403
SPDAHLPPSQLLGSS	ZFHX2	686	Q9C0A1
ATVEPASPTPAHSLP	SPHK2	381	Q9NRA0
LPLPHSSSPEHNRPT	SSH2	1076	Q76I76
TPIPSTPPAFSHDLS	SPEM3	431	A0A1B0GUW6
SQAPSRSPTPVHSPD	SHANK3	1121	Q9BYB0
PHSLPSPDPDILSVS	STIM2	551	Q9P246
PAELSPTTLSPVNHS	SMAD2	246	Q15796
SETLASPQSLPPASP	TUT1	296	Q9H6E5
TNTSISHESPVLPPP	SPATA31D1	536	Q6ZQQ2
LVLPPTQSSSDSSPP	ZC3H11A	726	O75152
EPSPKAPPLSSSTIH	ZNF574	111	Q6ZN55
LPPSSHEILSPQPQS	ZBTB41	831	Q5SVQ8
VAPTSEPSSPLHTQL	SRGAP2	986	O75044
NSPAPHAPSTSSPAD	TMEM131	1836	Q92545
SLLSLQHPPSTAPPV	HIVEP3	521	Q5T1R4
DLSSVPSLPVPHPAQ	NFATC3	711	Q12968
TPRSNPSPAPTDHSL	TENM4	206	Q6N022
LHPSLPSPTGNSTPL	TBC1D10B	701	Q4KMP7
SPKHPTPGSSDPLIQ	MAPT	411	P10636
PPSAAEHIVSPSAPA	TACC2	1911	O95359
RTQDKATHPPPASPS	RGS14	466	O43566
PPPATHLSPLDSAHT	TNFRSF25	246	Q93038
FPPSATLHLSNIPPS	PTBP3	471	O95758
PHLPPTSASSQQPLL	ZNF362	56	Q5T0B9
DTPAPPTHALSQSPA	SNAPC4	1151	Q5SXM2
PTSIHTDKSTNSPPP	SOX5	371	P35711
HTQPTPEPSTAPSTS	TNFRSF1B	226	P20333
DKHSVTAATPPPSPT	XPO6	196	Q96QU8
SSPEHLPATPAESPA	SUDS3	236	Q9H7L9
PSTSPDTHPALPLLE	SLC14A2	31	Q15849
PPSATLHLSNIPPSV	PTBP1	451	P26599
PSTKEPSTHIPPLDS	PPP1R1A	151	Q13522
QSSSRLQPPFSPHPT	USP36	746	Q9P275
LQPPFSPHPTLLSST	USP36	751	Q9P275
PGHPSLPSLPSNSSQ	AVPR2	11	P30518
EHSIPTPPTSAAPSE	KIAA0319	301	Q5VV43